CN1747733A - 通过局部施用氟喹诺酮类治疗呼吸器官的细菌疾病 - Google Patents
通过局部施用氟喹诺酮类治疗呼吸器官的细菌疾病 Download PDFInfo
- Publication number
- CN1747733A CN1747733A CNA2004800039275A CN200480003927A CN1747733A CN 1747733 A CN1747733 A CN 1747733A CN A2004800039275 A CNA2004800039275 A CN A2004800039275A CN 200480003927 A CN200480003927 A CN 200480003927A CN 1747733 A CN1747733 A CN 1747733A
- Authority
- CN
- China
- Prior art keywords
- ciprofloxacin
- solid
- betaine
- iii
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Description
剂量分组 | 血药浓度[mg*h/l] | Cmax[mg/l] | t1/2[h] |
A1 | 124 | 49.1 | 1.96 |
A2 | 304 | 76 | 13.47 |
B | 3.20 | 6.65 | 0.847 |
C | 0.497 | 0.610 | 0.758 |
剂量分组 | 0.25小时 | 0.5小时 | 1小时 | 3小时 | 5小时 |
A1 | 49.1 | 44.3 | 40.1 | 12.6 | 7.21 |
A2 | 76 | 76 | 76 | 54 | 54 |
B | 6.65 | 1.67 | 0.63 | 0.10 | 0 |
C | 0.61 | 0.35 | 0.14 | 0 | 0 |
剂量分组 | 微生物数量的降低(log-个体) |
A-0.8mg/kg环丙沙星内铵盐i.t. | -4.0 |
B-2.5mg/kg环丙沙星内铵盐i.t. | -5.8 |
C-7.5mg/kg环丙沙星内铵盐i.t. | -10 |
D-0.8mg/kg盐酸环丙沙星i.t. | -1.8 |
E-2.5mg/kg盐酸环丙沙星i.t. | -1.1 |
F-7.5mg/kg盐酸环丙沙星i.t. | -2.8 |
G-2.5mg/kg盐酸环丙沙星i.v. | -2.8 |
H-7.5mg/kg盐酸环丙沙星i.v. | -3.5 |
I-22.5mg/kg盐酸环丙沙星i.v. | -5.4 |
J-67.5mg/kg盐酸环丙沙星i.v. | -8.8 |
Claims (7)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10305319.0 | 2003-02-10 | ||
DE10305318.2 | 2003-02-10 | ||
DE10305319A DE10305319A1 (de) | 2003-02-10 | 2003-02-10 | Behandlung bakteriell verursachter Lungenkrankheiten |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1747733A true CN1747733A (zh) | 2006-03-15 |
CN100566715C CN100566715C (zh) | 2009-12-09 |
Family
ID=32747666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004800039275A Expired - Fee Related CN100566715C (zh) | 2003-02-10 | 2004-01-28 | 通过局部施用氟喹诺酮类治疗呼吸器官的细菌疾病 |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN100566715C (zh) |
DE (1) | DE10305319A1 (zh) |
ZA (1) | ZA200506287B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102099009B (zh) * | 2008-05-15 | 2014-07-02 | 诺华股份有限公司 | 氟喹诺酮类的肺部递送 |
CN109260180A (zh) * | 2017-07-17 | 2019-01-25 | 北京盈科瑞创新药物研究有限公司 | 一种盐酸莫西沙星雾化吸入用溶液制剂及其制备方法 |
-
2003
- 2003-02-10 DE DE10305319A patent/DE10305319A1/de not_active Withdrawn
-
2004
- 2004-01-28 CN CNB2004800039275A patent/CN100566715C/zh not_active Expired - Fee Related
-
2005
- 2005-08-05 ZA ZA200506287A patent/ZA200506287B/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102099009B (zh) * | 2008-05-15 | 2014-07-02 | 诺华股份有限公司 | 氟喹诺酮类的肺部递送 |
US9155732B2 (en) | 2008-05-15 | 2015-10-13 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
CN109260180A (zh) * | 2017-07-17 | 2019-01-25 | 北京盈科瑞创新药物研究有限公司 | 一种盐酸莫西沙星雾化吸入用溶液制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
ZA200506287B (en) | 2006-10-25 |
CN100566715C (zh) | 2009-12-09 |
DE10305319A1 (de) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6941224B2 (ja) | 疾患の処置のための鼻腔内エピネフリン製剤及び方法 | |
US20120010215A1 (en) | Treatment of bacterial diseases of the respiratory organs | |
HRP20110129T1 (hr) | Sastavi koji sadrže kristalni trans-(+/-)-delta-9-tetrahidrokanabinol | |
CN105832715B (zh) | 炎症调节剂用于治疗囊性纤维化和其他肺部疾病中的感染的用途 | |
US11026950B2 (en) | Methods and compositions for treating mesothelioma and small lung cancer that express midkine | |
JP2011506516A (ja) | 膵嚢胞性線維症の予防および/または対症治療のための医薬組成物 | |
CN100566715C (zh) | 通过局部施用氟喹诺酮类治疗呼吸器官的细菌疾病 | |
KR20110017433A (ko) | 비강내 투여용 케토로락의 약학적 제형물 | |
KR102375232B1 (ko) | 비강내 에피네프린 제제 및 질환의 치료 방법 | |
US20230372345A1 (en) | Inhaled PDE-V Inhibitor Drugs | |
WO2021211850A1 (en) | Inhalable formulation of a solution containing olodaterol | |
WO2021211854A1 (en) | Inhalable formulation of a solution containing tiotropium bromide | |
CN115137713A (zh) | 一种两性霉素b雾化吸入制剂及其制备方法 | |
WO2022256379A1 (en) | Inhalable pharmaceutical formulations | |
CN114848588A (zh) | 一种福多司坦吸入用溶液制剂及其制备方法和用途 | |
KR20190044552A (ko) | 호흡기 질환 예방 및 치료용 약학 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1089380 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BAYER SCHERING PHARMA AG Free format text: FORMER OWNER: BAYER HEALTHCARE AG Effective date: 20091120 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20091120 Address after: Berlin Patentee after: Bayer Schering Pharma AG Address before: Germany Leverkusen Patentee before: Bayer Healthcare AG |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1089380 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH Free format text: FORMER OWNER: BAYER PHARMACEUTICALS AG Effective date: 20130327 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: BAYER PHARMACEUTICALS AG Free format text: FORMER NAME: BAYER SCHERING PHARMA AG |
|
CP01 | Change in the name or title of a patent holder |
Address after: Berlin Patentee after: BAYER PHARMA AG Address before: Berlin Patentee before: Bayer Schering Pharma AG |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130327 Address after: German Monheim Patentee after: BAYER INTELLECTUAL PROPERTY GmbH Address before: Berlin Patentee before: BAYER PHARMA AG |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20091209 Termination date: 20190128 |
|
CF01 | Termination of patent right due to non-payment of annual fee |